Genfit S.A. (EPA:GNFT)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	167	176	176	197	215	155
Market Cap Growth	0.17%	0.17%	-10.69%	-8.19%	38.52%	-77.37%
Enterprise Value	147	182	140	63	181	114
Last Close Price	3.36	3.54	3.54	3.97	4.32	3.99
PE Ratio	111.87	116.97	-	-	3.19	-
Forward PE	-	25.71	-	-	-	-
PS Ratio	2.36	2.49	5.10	7.51	2.51	17.85
PB Ratio	2.41	2.55	2.59	2.08	1.80	-9.43
P/TBV Ratio	7.87	8.31	9.17	3.90	1.81	-
P/FCF Ratio	11.47	12.10	-	-	2.16	-
P/OCF Ratio	10.75	11.34	-	-	2.15	-
EV/Sales Ratio	2.09	2.58	4.05	2.39	2.12	13.11
EV/EBITDA Ratio	31.42	38.87	-	-	5.19	-
EV/EBIT Ratio	49.50	61.24	-	-	5.63	-
EV/FCF Ratio	10.12	12.52	-	-	1.82	-
Debt / Equity Ratio	0.90	0.90	1.03	0.80	0.62	-11.30
Debt / EBITDA Ratio	13.24	13.24	-	-	2.13	-
Debt / FCF Ratio	4.26	4.26	-	-	0.75	-
Asset Turnover	0.44	0.44	0.18	0.11	0.36	0.03
Quick Ratio	1.19	1.19	2.87	3.97	4.23	5.89
Current Ratio	1.23	1.23	2.94	4.03	4.27	5.95
Return on Equity (ROE)	2.20%	2.20%	-35.57%	-22.21%	131.02%	-299.31%
Return on Assets (ROA)	1.15%	1.15%	-9.91%	-6.95%	8.38%	-18.85%
Return on Capital (ROIC)	1.38%	1.38%	-12.53%	-9.51%	11.09%	-21.91%
Return on Capital Employed (ROCE)	3.90%	3.90%	-	-	14.70%	-
Earnings Yield	0.90%	0.85%	-16.42%	-12.04%	31.34%	-65.33%
FCF Yield	8.72%	8.27%	-31.73%	-36.87%	46.36%	-62.78%
Buyback Yield / Dilution	-0.50%	-0.50%	-0.05%	10.68%	-43.12%	-5.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.